These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 25544686)

  • 1. Evaluating the risk of phospholipidosis using a new multidisciplinary pipeline approach.
    Goracci L; Buratta S; Urbanelli L; Ferrara G; Di Guida R; Emiliani C; Cross S
    Eur J Med Chem; 2015 Mar; 92():49-63. PubMed ID: 25544686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In Silico Studies of the Relationship Between Chemical Structure and Drug Induced Phospholipidosis.
    Przybylak KR; Cronin MT
    Mol Inform; 2011 May; 30(5):415-29. PubMed ID: 27467088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cationic amphiphilic drug-induced phospholipidosis.
    Halliwell WH
    Toxicol Pathol; 1997; 25(1):53-60. PubMed ID: 9061852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug-induced phospholipidosis is caused by blockade of mannose 6-phosphate receptor-mediated targeting of lysosomal enzymes.
    Ikeda K; Hirayama M; Hirota Y; Asa E; Seki J; Tanaka Y
    Biochem Biophys Res Commun; 2008 Dec; 377(1):268-74. PubMed ID: 18840403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the phospholipidogenic potential of 4(1H)-pyridone antimalarial derivatives.
    Almela MJ; Torres PA; Lozano S; Herreros E
    Toxicol In Vitro; 2009 Dec; 23(8):1528-34. PubMed ID: 19540329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of metabolic activation leading to drug-induced phospholipidosis in rat hepatocyte spheroids.
    Takagi M; Sanoh S; Santoh M; Ejiri Y; Kotake Y; Ohta S
    J Toxicol Sci; 2016 Feb; 41(1):155-64. PubMed ID: 26763403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Why are most phospholipidosis inducers also hERG blockers?
    Slavov S; Stoyanova-Slavova I; Li S; Zhao J; Huang R; Xia M; Beger R
    Arch Toxicol; 2017 Dec; 91(12):3885-3895. PubMed ID: 28551711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of drugs inducing phospholipidosis by novel in vitro data.
    Muehlbacher M; Tripal P; Roas F; Kornhuber J
    ChemMedChem; 2012 Nov; 7(11):1925-34. PubMed ID: 22945602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different Sensitivity of Macrophages to Phospholipidosis Induction by Amphiphilic Cationic Drugs.
    Öhlinger K; Absenger-Novak M; Meindl C; Ober J; Fröhlich E
    Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33182310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computational identification of a phospholipidosis toxicophore using (13)C and (15)N NMR-distance based fingerprints.
    Slavov SH; Wilkes JG; Buzatu DA; Kruhlak NL; Willard JM; Hanig JP; Beger RD
    Bioorg Med Chem; 2014 Dec; 22(23):6706-6714. PubMed ID: 25228124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydrophilic interaction chromatography with a focus on the drug-phosphate interaction in drug screening to determine the phospholipidosis induction risk.
    Okamoto H; Hamaguchi R; Kuroda Y
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Apr; 1051():33-40. PubMed ID: 28285021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting in vivo phospholipidosis-inducing potential of drugs by a combined high content screening and in silico modelling approach.
    Bauch C; Bevan S; Woodhouse H; Dilworth C; Walker P
    Toxicol In Vitro; 2015 Apr; 29(3):621-30. PubMed ID: 25668432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction and Consensus Performance of (Q)SAR Models for Predicting Phospholipidosis Using a Dataset of 743 Compounds.
    Orogo AM; Choi SS; Minnier BL; Kruhlak NL
    Mol Inform; 2012 Oct; 31(10):725-39. PubMed ID: 27476455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From the Cover: Potentiation of Drug-Induced Phospholipidosis In Vitro through PEGlyated Graphene Oxide as the Nanocarrier.
    Yang L; Zhong X; Li Q; Zhang X; Wang Y; Yang K; Zhang LW
    Toxicol Sci; 2017 Mar; 156(1):39-53. PubMed ID: 28013220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro detection of drug-induced phospholipidosis using gene expression and fluorescent phospholipid based methodologies.
    Nioi P; Perry BK; Wang EJ; Gu YZ; Snyder RD
    Toxicol Sci; 2007 Sep; 99(1):162-73. PubMed ID: 17567588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between in vitro phospholipidosis assay using HepG2 cells and 2-week toxicity studies in rats.
    Miyamoto S; Matsumoto A; Mori I; Horinouchi A
    Toxicol Mech Methods; 2009 Oct; 19(8):477-85. PubMed ID: 19793005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phospholipidosis effect of drugs by adsorption into lipid monolayers.
    Ceccarelli M; Germani R; Massari S; Petit C; Nurisso A; Wolfender JL; Goracci L
    Colloids Surf B Biointerfaces; 2015 Dec; 136():175-84. PubMed ID: 26387069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A role for lysosomal phospholipase A2 in drug induced phospholipidosis.
    Abe A; Hiraoka M; Shayman JA
    Drug Metab Lett; 2007 Jan; 1(1):49-53. PubMed ID: 19356018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation and validation of multiple cell lines and primary mouse macrophages to predict phospholipidosis potential.
    LeCureux L; Cheng CS; Herbst J; Reilly TP; Lehman-McKeeman L; Otieno M
    Toxicol In Vitro; 2011 Dec; 25(8):1934-43. PubMed ID: 21767630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A cell-based approach for the early assessment of the phospholipidogenic potential in pharmaceutical research and drug development.
    Casartelli A; Bonato M; Cristofori P; Crivellente F; Dal Negro G; Masotto I; Mutinelli C; Valko K; Bonfante V
    Cell Biol Toxicol; 2003 Jun; 19(3):161-76. PubMed ID: 12945744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.